Equillium receives Nasdaq minimum bid price non-compliance notice; cure period until June 11, 2025

Equillium, Inc.

Nasdaq notified Equillium on Dec 13, 2024 that common stock bid price was below $1.00 for 30 consecutive business days.
Company has 180 calendar days, until June 11, 2025, to regain compliance with the Minimum Bid Price Requirement.
To cure, minimum bid must close at $1.00 or higher for at least ten consecutive business days during the grace period.
If not cured by June 2025, Equillium may qualify for a second 180-day compliance period if it meets other listing standards.
Equillium intends to monitor bid price and is considering options such as a reverse stock split to regain compliance.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.